By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical this week said it has filed the final prospectus for its offering to raise C$8 million (US$7.9 million).

Under the offerings' terms, each Response shareholder of record on Dec. 7, 2011 will be able to receive one right for each held share. Each right will be exercisable for 2.7532 units, with each unit consisting of one common share and one common share purchase warrant at a price of C$.0746 per unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.